2025 past events and seminars
-
Economic Evaluation seminar - A multistate disease modeling approach to projecting population outcomes of Multicancer Detection Testing
Speaker - Jane Lange, Staff Scientist, CEDAR, OHSU Knight Cancer Institute, School of Medicine
-
Economic Evaluation seminar - Evidence Following Conditional NICE Technology Appraisal Recommendations: A Critical Analysis of Methods, Quality and Risk of Bias
Speaker: Professor Dyfrig Hughes, Senior Research Leader, Bangor University
-
CHE seminar - How redistributive is the English NHS?
Speaker: George Stoye, Deputy Director, Institute for Fiscal Studies
-
Global Health Seminar - The impact of discontinuing Seguro Popular on diabetes management and neonatal mortality in Mexico
Speaker: Diego Cerecero Garcia, Imperial College London
-
CHE seminar - Uncontrolled studies aka single arm trials: Why? And what can we do with them?
Speaker: Dr Anthony Hatswell, Chief Scientific Officer, Delta Hat
-
Economic Evaluation seminar - Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations
Speaker - David Lugo-Palacios, Assistant Professor in Health Economics, Department of Health Services Research & Policy, London School of Hygiene & Tropical Medicine
-
The REAL Units' Health Economics and Policy Seminar Series: ‘The Reform and Innovation Challenge for the NHS’
As part of the joint REAL Supply and REAL Demand Research Units' Health Economics and Policy Seminar Series, we are delighted to be hosting Matthew Taylor, CEO of NHS Confederation, presenting: The Reform and Innovation Challenge for the NHS
-
Global Health Seminar - Can Governments Save on Diabetes Costs with Pooled Procurement? The effect of the COMISCA Joint Negotiation Mechanism on the prices of insulin in Central America.
Alexandra Quiñones Nunura, Centre for Health Economics, University of York